[In vitro and in vivo effects of trimethoprim-sulfamethoxazole on Yersinia pestis].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D004338:Drug Combinations; D005493:Folic Acid Antagonists / Q000627:therapeutic use*; D066298:In Vitro Techniques; D051379:Mice; D008826:Microbial Sensitivity Tests; D010930:Plague / Q000188:drug therapy*; D011743:Pyrimidines / Q000627:therapeutic use*; D013420:Sulfamethoxazole / Q000494:pharmacology / Q000627:therapeutic use*; D014295:Trimethoprim / Q000494:pharmacology / Q000627:therapeutic use; D015010:Yersinia pestis / Q000187:drug effects*
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D014295:Trimethoprim; D013420:Sulfamethoxazole
Effets in vitro et in vivo du triméthoprime-sulfaméthoxazole sur Yersinia pestis.